Welcome to the Leppert Lab
Our research aims to improve the global quality of care for patients with Urologic cancer, with a particular focus on kidney cancer. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are investigating nanofluidic proteomic assays to diagnose kidney cancer and identify signatures of response to therapy. We are also applying epidemiology, bioinformatics, and health services methods to urologic conditions. Finally, we are evaluating surgical technologies that are applicable to endoscopic, laparoscopic and robotic surgery.
We are part of the Stanford University, Stanford School of Medicine in the Department of Urology, and are members of the Cancer Institute and the Bio-X program.
Dr. Lee receives best poster award at AUA
5/5/2013:Dr. Lee received a best poster award for her presentation at the AUA on EWAS methodology for prostate cancer.
More »
Dr. Weinberg received best poster award at the AUA
5/4/2013: Dr. Weinberg received a best poster award for her presentation at the AUA on diabetic severity and kidney stone risk.
More »
Dr. Weinberg receives resident research award
4/13/2013: For the second straight year, one of our Stanford residents has received first prize in the clinical research category at the Northern California Research Program. Dr. Weinberg presented her analysis of measures of diabetic severity and the risk of kidney stone disease.
More »
Dr. Weinberg publishes work in European Urology
3/3/2013: Congratulations to Dr. Weinberg. Her analysis of diabetic severity and kidney stone risk was published in European Urology.
More »
Dr. Leppert Completes Epidemiology Program
1/15/2013: Dr. Leppert has completed his M.S. degree in Epidemiology as part of the
Graduate Program in Clinical Epidemiology at Stanford University. This work was part of the career development plan established in the NIDDK K23 Award studying kidney disease outcomes following kidney cancer surgery.
More »
Lab Welcomes Two Members
1/7/2013: Welcome Thomas Metzner and Jinn Thomas to the Leppert Lab! Thomas will serve as a hydrbid life sciences research assistant and clinical research coordinator focusing on kidney cancer translational projects. Jinn joins the lab as a statistician and programmer working with VA data for kidney cancer.
More »
Lab Receives NCI Grant
7/24/2012: Drs. Felsher and Leppert have been awarded a R21 award to study "Nanoscale proteomic profiles of hypoxia pathways to develop biomarkers of renal cell carcinoma."
More »
Lab Receives Stanford Cancer Institute Grant
7/18/2012: Drs. Rhoads and Leppert have been award a Developmental Cancer Research Award. This funding will support a new collaboration to study patient and hospital characteristics that contribute to variation in surgical care for kidney cancer in California.
More »
Stanford Biodesign Team Wins Business Competitions
5/9/2012: Congratulations to the Stanford Biodesign "Red" Team, winners of multiple business plan competitions while developing a novel device to treat kidney stones.
More »
Dr. Liu receives resident research award
4/14/2012: Congratulations to Dr. Jen-Jane Liu (Resident, Stanford Urology) who was awarded first prize in the clinical research category at the Northern California Urology Research Program. Her research evaluated the survival and outcomes for Veterans with bladder cancer using the VA Central Cancer Registry.
Collaborator Receives Stanford Translational Medicine Grant
10/3/2011: Collaborator Dr. Harshman (Stanford, Oncology) has received a Translational Research and Applied Medicine (TRAM) pilot grant for the project, "Development of blood biomarkers for diagnosis and monitoring of renal cell carcinoma."
More »
Lab Receives Stanford Cancer Institute Grant
9/6/2011: Our group has been awarded a Developmental Cancer Research Award. This funding will support the development biomarkers used to diagnose kidney cancer and monitor the response of tumors to treatment.
More »
Lab Receives NIDDK Grant
9/15/2010: Dr. Leppert has been awarded a Career Development Award to study the comparative effectiveness on kidney cancer surgery on downstream clinical outcomes.
More »
